Patients denied osteoporosis drug (The Guardian, 8 September 2009)

10 Sept 2009


Professor David Reid (University of Aberdeen) has raised concerns over the licensing of osteoporosis drugs by the National Institute for Health and Clinical Excellence (NICE). Professor Reid delivered a lecture on the treatment of osteoporosis during the British Science Festival at an event organised by the Society for Endocrinology and National Osteoporosis Society.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story